5-Fluoro-AET

5-Fluoro-AET
Clinical data
Other names	5-Fluoro-α-ethyltryptamine; 5-F-AET; 5F-AET; 5-Fluoro-αET; 5-F-αET; 5F-αET
Identifiers
	IUPAC name 1-(5-fluoro-1H-indol-3-yl)butan-2-amine;
CAS Number	1380137-98-3 ;
PubChem CID	118713118;
ChemSpider	26955850;
ChEMBL	ChEMBL3330648;
Chemical and physical data
Formula	C12H15FN2
Molar mass	206.264 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCC(CC1=CNC2=C1C=C(C=C2)F)N;
	InChI InChI=1S/C12H15FN2/c1-2-10(14)5-8-7-15-12-4-3-9(13)6-11(8)12/h3-4,6-7,10,15H,2,5,14H2,1H3; Key:QGUZSMSUGSSPNJ-UHFFFAOYSA-N;

5-Fluoro-AET, also known as 5-fluoro-α-ethyltryptamine, is a substituted tryptamine derivative which acts as a serotonin–dopamine releasing agent (SDRA) and agonist of the serotonin 5-HT_2A receptor.^[1]

References

^ Blough BE, Landavazo A, Partilla JS, Decker AM, Page KM, Baumann MH, Rothman RB (October 2014). "Alpha-ethyltryptamines as dual dopamine-serotonin releasers". Bioorganic & Medicinal Chemistry Letters. 24 (19): 4754–4758. doi:10.1016/j.bmcl.2014.07.062. PMC 4211607. PMID 25193229.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.